Epstein-Barr virus negative large B-cell lymphoma during long term immunomodulatory therapy for T-cell large granular lymphocytic leukaemia.
Anoop
Parameswaran
P
Ravindranathan
Girish
G
Osuji
Nnenna
N
Dearden
Claire E
CE
Wotherspoon
Andy
A
Bain
Barbara J
BJ
Matutes
Estella
E
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001706:Biopsy; D003520:Cyclophosphamide; D018450:Disease Progression; D004317:Doxorubicin; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D054066:Leukemia, Large Granular Lymphocytic / Q000188:drug therapy*; D008228:Lymphoma, Non-Hodgkin / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D008297:Male; D008727:Methotrexate / Q000009:adverse effects* / Q000627:therapeutic use; D011241:Prednisone; D016896:Treatment Outcome; D014750:Vincristine
D007166:Immunosuppressive Agents; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone; D008727:Methotrexate